Skip to Content

Clinical Trials Search Results

Showing 1-2 of 2

Sorted By:

  • Acorn MDV3100-11

    A Phase 2, Single-Arm, Open-Label, Multicenter Study of the Clinical Activity and Safetyof Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple-Negative Breast Cancer

  • Novartis CRAD001Y24135

    An open-label, Phase II Single-Arm study of Everolimus in combination with Letrozole in the treatment of postmenopausal women with estrogen receptor positive Metastatic Breast Cancer

Showing trials 1-2 of 2

Also in this Section